Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lubiprostone adjunct with modified PEG3350-electrolyte-vitamin C for same-day bowel preparation before afternoon colonoscopy
ChiCTR2600133561Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- May 2026
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of cobiprostone, polyethylene glycol 3350 and ascorbic acid in inadequate bowel preparation (IBP) (3 arms), sponsored by Tongji Hospital. Primary endpoint: Rate of adequate bowel preparation. Planned start May 2026; status: not yet recruiting.
02
Drugs
cobiprostonepolyethylene glycol 3350ascorbic acid
03
Conditions
inadequate bowel preparation (IBP)
Beyond the preview
Go deeper on ChiCTR2600133561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133561.